Intravitreal use of triamcinolone acetonide: an experimental clinical procedure
- 27 September 2005
- journal article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 83 (5) , 526-527
- https://doi.org/10.1111/j.1600-0420.2005.00538.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Predictive Factors for Visual Acuity After Intravitreal Triamcinolone Treatment for Diabetic Macular EdemaArchives of Ophthalmology (1950), 2005
- Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow‐upActa Ophthalmologica Scandinavica, 2005
- Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot studyActa Ophthalmologica Scandinavica, 2005
- Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide InjectionOphthalmology, 2005
- Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcomeActa Ophthalmologica Scandinavica, 2005
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataractOphthalmology, 2004
- Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edemaAmerican Journal of Ophthalmology, 2004
- Serum levels of triamcinolone acetonide after intravitreal injectionAmerican Journal of Ophthalmology, 2004
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology, 2003